Stock FGEN FIBROGEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts FibroGen, Inc.

Equities

FGEN

US31572Q8087

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.2 USD +4.35% Intraday chart for FibroGen, Inc. -7.69% +35.39%
May. 23 FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer at the 2024 American Society of Clinical Oncology Annual Meeting CI
May. 07 Top Premarket Gainers MT

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Neutral

Neutral

Neutral

Resistance 1.370 2.730 2.730
Spread/Res.-12.41%-56.04%-56.04%
Spread/Supp.+21.91%+116.33%+215.71%
Support 0.9843 0.5547 0.3801

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. FGEN Stock
  4. Charts FibroGen, Inc.